117 related articles for article (PubMed ID: 6698083)
1. The value of histologic grading and staging, random biopsies, tumor and bladder mucosa blood group antigens, in predicting progression of superficial bladder cancer.
Huland H; Klöppel G; Otto U; Droese M
Eur Urol; 1984; 10(1):28-31. PubMed ID: 6698083
[TBL] [Abstract][Full Text] [Related]
2. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
[TBL] [Abstract][Full Text] [Related]
3. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
[TBL] [Abstract][Full Text] [Related]
4. Bladder tumors: when to do and what to expect from random mucosal biopsies with reference to blood group cell surface antigens.
Boccon-Gibod L; Boccon-Gibod L; Desligneres S; Janin-Mercier A
Eur Urol; 1987; 13(1-2):1-6. PubMed ID: 3582436
[TBL] [Abstract][Full Text] [Related]
5. [Bladder tumors. Indications and results of systematic biopsies of optically normal mucosa (with a study of surface antigens)].
Boccon-Gibod L; Boccon-Gibod L; Deslignères S; Janin-Mercier A
Arch Anat Cytol Pathol; 1986; 34(4):224-9. PubMed ID: 3566364
[No Abstract] [Full Text] [Related]
6. Prognostic significance of ABH antigenicity of mucosal biopsies in superficial bladder cancer.
Das G; Buxton NJ; Stewart PA; Glashan RW
J Urol; 1986 Dec; 136(6):1194-6. PubMed ID: 3534312
[TBL] [Abstract][Full Text] [Related]
7. [Behavior of the ABO(H) blood group antigens of the urothelial surface in bladder tumors].
Proca E; Lucan M; Pîslăraşu M
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(6):401-12. PubMed ID: 2964680
[No Abstract] [Full Text] [Related]
8. [Significance of urothelial dysplasia in macroscopically normal mucosa in patients with bladder tumors. Results of a randomized study with and without intravesical mitomycin C in the prevention of recurrence].
Maier U; Holzner JH
Onkologie; 1985 Aug; 8(4):232-40. PubMed ID: 3937968
[TBL] [Abstract][Full Text] [Related]
9. Random biopsies in bladder tumors: in most cases, you shall not!
Zlotta AR
Eur Urol; 2006 Aug; 50(2):186-93. PubMed ID: 16814925
[No Abstract] [Full Text] [Related]
10. [Studies on multiple mucosal biopsy in patients with bladder cancer. 3. Evaluation of ABH antigenicity in specimens of multiple mucosal biopsy and transitional cell carcinoma of the bladder].
Igawa M
Hinyokika Kiyo; 1986 Nov; 32(11):1649-62. PubMed ID: 3825814
[TBL] [Abstract][Full Text] [Related]
11. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
[TBL] [Abstract][Full Text] [Related]
12. [Significance of isoantigen in the management of the urinary bladder tumor--a basic study of ABO isoantigen in step sections of the entire bladder].
Ogawa T; Sugimoto M; Hamami G; Kamidono S
Hinyokika Kiyo; 1989 Jan; 35(1):13-25. PubMed ID: 2729014
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis of superficial urothelial tumors of the bladder. Evaluation possibilities using the erythrocyte adherence test (SRCA test)].
Krüger R; Reuter F; Deilmann W
Pathologe; 1982 Sep; 3(5):266-71. PubMed ID: 7145864
[No Abstract] [Full Text] [Related]
14. Ta and T1 bladder cancer: location, recurrence and progression.
Heney NM; Nocks BN; Daly JJ; Prout GR; Newall JB; Griffin PP; Perrone TL; Szyfelbein WA
Br J Urol; 1982 Apr; 54(2):152-7. PubMed ID: 7082932
[TBL] [Abstract][Full Text] [Related]
15. Use of mitomycin as prophylaxis following endoscopic resection of superficial bladder cancer.
Huland H; Otto U
Urology; 1985 Oct; 26(4 Suppl):32-5. PubMed ID: 4049627
[TBL] [Abstract][Full Text] [Related]
16. Specific red cell adherence: immunologic evaluation of random mucosal biopsies in carcinoma of the bladder.
Stein BS; Reyes JM; Petersen RO; McNellis D; Kendall AR
J Urol; 1981 Jul; 126(1):37-40. PubMed ID: 6166759
[TBL] [Abstract][Full Text] [Related]
17. Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course.
Takashi M; Sakata T; Murase T; Hamajima N; Miyake K
Nagoya J Med Sci; 1991 Mar; 53(1-4):1-8. PubMed ID: 1805133
[TBL] [Abstract][Full Text] [Related]
18. Value of random mucosal biopsies in the management of superficial bladder cancer.
Mufti GR; Singh M
Eur Urol; 1992; 22(4):288-93. PubMed ID: 1490505
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of multiple mucosal biopsies in new cases of superficial papillary bladder tumor].
Kanamaru H; Shirahase T; Moroi S; Taniguchi T; Kuo JY; Okuno H; Kihara Y; Arai Y
Hinyokika Kiyo; 1993 Feb; 39(2):127-30. PubMed ID: 8465685
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer.
Smith G; Elton RA; Beynon LL; Newsam JE; Chisholm GD; Hargreave TB
Br J Urol; 1983 Dec; 55(6):665-9. PubMed ID: 6652436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
